The firm specializes in financial services litigation, a practice that requires both the analytical ability to understand complex economic issues and relationships and the sound judgment to exploit that understanding to maximize negotiated or litigated outcomes. Sperduto Thompson has undertaken numerous representations of Allied Capital Corporation and related entities in loan workout litigations and restructuring transactions. We have represented foreign investors in disputes involving domestic real estate investments. The firm has also represented corporate directors in fiduciary duty shareholder claims and minority shareholders in actions against majority owners. The firm also successfully represented the former minority shareholders in their takeover of Merlin Biomedical and Pharmaceutical, Ltd., a company that owns some of the most spectacular HIV point-of-care test results ever submitted for regulatory approval. Our financial services practice is increasingly characterized by preemptive counseling as numerous clients seek our early advice in order to anticipate and avert protracted litigation.
Mr. Sperduto has extensive experience in representing investment banks, broker-dealers, 1940 Act advisers, bank and thrift institutions, and other financial enterprises. He has represented Citicorp and Columbia First Federal Savings & Loan Association. He has also been involved with representation of American Express, Shearson Lehman Brothers, E. F. Hutton, and Rooney-Pace, Inc., among others. Mr. Sperduto has litigated securities fraud cases, hostile takeovers under the Williams Act, proxy fights for corporate control, SEC enforcement proceedings, RICO conspiracy challenges, and esoteric commodities issues involving entitlement to interest and increment. He has also participated in the defense of credit companies attacked in class actions for alleged violations of the truth-in-lending laws. While the firm's focus has been litigation, we are increasingly asked to represent financial services clients in transactional work.